510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K013305Substantially Equivalent

Enoxaparin Test Card

Cardiovascular Diagnostics, Inc., Morrisville NC / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K013305 is the FDA 510(k) clearance record for ENOXAPARIN TEST CARD, a class II device, cleared for Cardiovascular Diagnostics, Inc. on under FDA product code KFF (Assay, Heparin). FDA records list 13 510(k) clearances for Cardiovascular Diagnostics, Inc., from to . As of , FDA records show no recalls naming K013305.

Clearance record

Decision date
Received
(323 days to decision)
Product code
KFF Assay, Heparin
Regulation
21 CFR 864.7525
Device class
Class II
Review panel
Hematology
Applicant
Cardiovascular Diagnostics, Inc. 9401 Globe Center Dr.,Suite, Morrisville NC
510(k) summary
Summary
Third party review
No

Clearances, product code KFF

Trailing 12 months
1 clearance under product code KFF in the twelve months to October 2026, September 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code KFF, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20261
October 20260